Main Article Content

Is there transparency in the pricing of medicines in the South African private sector?


V Bangalee
F Suleman

Abstract

Recent investigations by the Competition Commission of South Africa (SA) of suspected excessive pricing of cancer medicines in SA by three global pharmaceutical companies have once again drawn attention to increasing medicine pricing transparency and warrant further public debate.


Journal Identifiers


eISSN: 2078-5135
print ISSN: 0256-9574